XEL
48
11
HPE
48
2
ADT
12
2
CRM
65
6
DLTR
52
8
EXR
42
5
DVA
62
5
CHD
34
7
CSCO
63
5
SO
48
6
MMC
46
5
BMY
40
-5
MCO
67
3
BAX
38
2
NI
63
5
PWR
63
3
GS
65
16
OXY
42
17
SCHW
40
3
UPS
51
6
XEL
48
11
HPE
48
2
ADT
12
2
CRM
65
6
DLTR
52
8
EXR
42
5
DVA
62
5
CHD
34
7
CSCO
63
5
SO
48
6
MMC
46
5
BMY
40
-5
MCO
67
3
BAX
38
2
NI
63
5
PWR
63
3
GS
65
16
OXY
42
17
SCHW
40
3
UPS
51
6
Financhill
Back

Candel Therapeutics 10K Form

Buy
59

CADL
Candel Therapeutics

Last Price:
$8.39
Seasonality Move:
-11.47%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CADL News And Ratings

See the #1 stock for the next 7 days that we like better than CADL

CADL Financial Statistics

Sales & Book Value

Annual Sales: $125K
Cash Flow: $-6.6M
Price / Cash Flow: 0
Annual Sales: $-0.47
Price / Book: 25.38

Profitability

EPS (TTM): -1.73000
Net Income (TTM): $-52.2M
Gross Margin: --
Return on Equity: 0%
Return on Assets: 0%

Candel Therapeutics Earnings Forecast

Key Candel Therapeutics Financial Ratios

  • The Interest Expense is -6.84% of Operating Income.
  • Per Share Earnings over the last 5 years have been positive in 1 years.

Candel Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: CADL
Website: candeltx.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

CADL Technical Analysis vs Fundamental Analysis

Buy
59
Candel Therapeutics (CADL) is a Buy

Is Candel Therapeutics a Buy or a Sell?